Apr 06, 2022 8:30am EDT IM Cannabis Strengthens Focus on Importing Premium and Ultra-Premium Products from its Canadian Subsidiaries
Mar 31, 2022 8:00am EDT IM Cannabis Reports Record Fourth Quarter and Fiscal Year 2021 Financial Results and Provides First Quarter 2022 Outlook
Mar 30, 2022 8:30am EDT IM Cannabis Closes Previously Announced Acquisition of Oranim Pharm, Jerusalem's Leading Medical Cannabis Pharmacy
Mar 29, 2022 8:30am EDT IM Cannabis Reschedules Fourth Quarter and Full Year 2021 Conference Call to Thursday, March 31 at 9:00 a.m. ET
Mar 23, 2022 8:00am EDT IM Cannabis to Report Fourth Quarter and Full Year 2021 Financial Results on Wednesday, March 30 at 9:00 a.m. ET
Mar 15, 2022 8:12am EDT IM Cannabis Closes Three Previously Announced Strategic Acquisitions in Israel
Mar 10, 2022 8:00am EST IM Cannabis Reports Record Preliminary Fourth Quarter and Full Year 2021 Financial Results
Feb 08, 2022 8:00am EST IM Cannabis Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communications Program
Jan 19, 2022 8:30am EST IM Cannabis announces Focus Medical's Import of 400 Kilograms of Premium-Indoor-Grown Dried Cannabis from Canada to Israel